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MULTIPLE INFECTIONS IN A PATIENT WITH IMMUN-
ODEFICIENCY WITH HYPER-IgM
Fernandez L, Rodriguez AJ, Barbella R, Lakatos
M; Pathology Department, Perez Carreño Hospital,
Caracas; DGSACS-MSDS, Maracay; Salud-Miranda,
Capaya; Salud-Baruta, Baruta; Venezuela
OBJECTIVE: To report infectious diseases and patho-
logical features in a patient with immunodeﬁciency
with hyper-IgM (IDHM).
METHODS: Immunological, clinical and pathological
features of infectious diseases in a patient with fa-
tal IDHM were studied.
RESULTS: Patient was male, 14 month-old at di-
agnosis and death. Patient came to our hospital
with clinical signs of CNS infection. Initial diag-
nosis: Bacterial meningitis, cutaneous candidiasis,
diarrhea and measles. Patient presented aglob-
ulinemia of IgA and IgG. IgM: 840mg/dL. In CSF
cultures growth Streptococcus pneumoniae. In
stools cultures growth Salmonella and Serratia
marscecens. Patient had 2 doses of OPV and 2
doses of DPT, Patient died at 48 hrs of income
with sepsis due to Salmonella, Serratia marcescens
and Streptococcus pneumoniae. Main pathologi-
cal ﬁnding was hypoplasia of lymphoid tissues and
leptomeningitis.
CONCLUSIONS: IDHM syndrome is characterized by
levels of IgM ranging 150—1000mg/dL associated
with deﬁciency of IgG and IgA. This syndrome has
been associated with EVB infection. Cryptosporid-
iosis has been reported as infectious complication
in this pathology. We concluded that severe infec-
tions due Salmonella and Serratia but especially due
to S. pneumoniae are related to deﬁciency of IgG.
Further studies are needed in Venezuela to deter-
minate real incidence of IDHM and other primary
immunodeﬁencies in a country with elevated child
mortality due to apparent respiratory tract infec-
tions and diarrhea.
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INFECTIOUS DISEASES IN PATIENTS WITH COM-
BINED IMMUNODEFICIENCY
Fernandez L, Rodriguez AJ*, Barbella R, Lakatos
M; Pathology Department, Perez Carreño Hospital,
Caracas; DGSACS-MSDS, Maracay; Salud-Miranda,
Capaya; Salud-Baruta, Baruta; Venezuela
OBJECTIVE: To study infectious diseases and patho-
logical features of patients with combined immun-
odeﬁciency (CID).
METHODS: Immunological, clinical and pathological
features of infectious diseases in patients with fa-
tal CID were studied in two patients seen at Perez
Carreño Hospital, Caracas.
RESULTS: Patients were one male and one fe-
male, with 5 and 3 months of age at diagnosis
and death. First patient came to our hospital
with severe dehydratation due to diarrhea and
malnutrition; and second with severe dermatosis
and severe dehydratation due to diarrhea. Initial
diagnoses: bronchopneumonia, enterocolitis and
diarrhea (ﬁrst patient) and diarrhea and pneu-
monia (second patient). Both patients presented
hypogammaglobulinemia. Clinical studies showed
as infectious aetiological agents: Pneumocystis
carinni, Salmonella group B and Escherichia coli
(ﬁrst patient) and E. coli and Pseudomonas aerug-
inosa (second patient). No polymicrobial infec-
tions were seen in these patients. Patients died at
24 hrs of infection with sepsis. Pathological stud-
ies concluded: CID. Pathological ﬁndings were:
at lymphatic nodes: absent germinal centers and
hypoplasia (respectively), no Peyer plaques and
poor lymphocytic population in amigdala (ﬁrst pa-
tient), erythrophagocytosis at bone marrow (sec-
ond patient).
CONCLUSIONS: Infections seen in patients with CID
commonly include candidiasis, pneumonia, otitis
media and septicemia. Frequent agents of these
infections are Candida, CMV and Pneumocystis
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carinii, as we seen in one patient with PCP. But
these patients develop susceptibility to a wide
range of gram-positive and gram-negative organ-
isms, as in both patients with severe infections due
E. coli, P. aeruginosa and Salmonella. CID is associ-
ated with complete failure of cellular and humoral
immunity, with lymphopenia and hypogammaglob-
ulinemia as we saw in both patients. Further stud-
ies are needed in Venezuela to determinate real
incidence of CID and other primary immunode-
ﬁencies in a country with elevated child mortality
due to apparent respiratory tract infections and
diarrhea.
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PYELONEPHRYTIS DUE TO Proteus mirabilis IN A
PATIENT WITH AGAMMAGLOBULINEMIA (BRUTON
DISEASE)
Fernandez L, Rodriguez AJ*, Barbella R, Lakatos
M; Pathology Department, Perez Carreño Hospital,
Caracas; DGSACS-MSDS, Maracay; Salud-Miranda,
Capaya; Salud-Baruta, Baruta; Venezuela
OBJECTIVE: To report infectious diseases and patho-
logical features in a patient with agammaglobuline-
mia (Bruton disease [BD]).
METHODS: Immunological, clinical and pathological
features of infectious diseases in a patient with fa-
tal BD were studied.
RESULTS: Patient was male, 2 month-old at di-
agnosis and death. Patient came to our hospital
with severe dehydratation due to diarrhea and
clinical signs of upper urinary tract infection. Ini-
tial diagnosis: enterocolitis and pyelonephrytis.
Patient presented agammaglobulinemia. In stools
cultures grew Pseudomonas aeruginosa. In urine
cultures grew Proteus mirabilis. Patient died at
48 hrs of income with sepsis. Pathological studies
concluded: BD. Pathological ﬁndings were: pul-
monary edema, heart congestion, pyelonephrytis,
atrophic mucosa in bowel tissues and haemorrhagic
enterocolitis.
CONCLUSIONS: Fifty years ago a new disease,
agammaglobulinaemia, was described. This was
made possible by a great number of preceding
technical innovations and theories on different
ﬁelds of research. The widely used name ‘‘Bru-
ton disease’’ credits one single man with a new
observation which, however, was simultaneously
made by several physicians. Agammaglobulinaemia
was the ﬁrst example of an immunodeﬁciency syn-
drome. Infectious agents seen in patients with BD
commonly include Haemophilus inﬂuenzae, Can-
dida, grampositive organisms (especially Strepto-
coccus pneumoniae), virus ECHO, gramnegative
bacteria, as we saw in this patient. Further stud-
ies are needed in Venezuela to determinate real
incidence of BD and other primary immunodeﬁen-
cies in a country with elevated child mortality
due to apparent respiratory tract infections and
diarrhea.
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CD64 (FcgRI), CELL SURFACE EXPRESSION ON MA-
TURING NEUTROPHILS FROM PRETERM AND TERM
NEWBORN INFANTS
Fjaertoft G,* Håkansson L, Foucard T, Ewald U,
Venge P; Department of Women’s and Children’s
Health, Section of Pediatrics and Medical Sciences,
Section of Clinical Chemistry, University Hospital,
Uppsala Sweden
OBJECTIVE: The expression of CD64 (FcgRI) is in-
creased from an almost negligible to a marked level
on neutrophils in patients with bacterial infections.
CD64 expression on neutrophils might therefore be
a potential candidate for the diagnosis of bacterial
infections in infants. The aim of this study was to
monitor changes of neutrophil expression of CD64
during post-partum period to further evaluate the
usefulness of this analysis. The possible inﬂuence on
the expression of this receptor by other factors was
also investigated, including the respiratory distress
syndrome (RDS) and pretrm rupture of the mem-
branes (PROM).
METHODS: Cell surface expression of CD64 on neu-
trophils from preterm (n = 22) and term (n = 18)
newborn infants and healthy adults (n = 30) was
analysed by ﬂow cytometry. The expression of the
other Fcgamma receptors CD32 and CD16 and the
complement receptors CD11b/CD18 and CD35 were
also analysed for comparison.
RESULTS: Neutrophils from preterm newborn in-
fants showed a moderatly increased level of CD64
expression that, during their ﬁrst month of life,
was reduced to the level observed on neutrophils
from term newborn infants. In contrast, the level
of neutrophil expression of CD32 and CD16 was
signiﬁcantly lower in preterm than term neborn in-
fants. Neutrophils from all groups indicated similar
levels of CD11b expression, but the expression on
neutrophils from newborn infants increased after
birth.
CONCLUSIONS: Our results indicate that neutrophil
expression of CD64 is a reliable indicator of bac-
terial infection in preterm and term newborn in-
fants. It seems inﬂuenced by bacterial infections
only and not by RDS, PROM, or other factors related
to preterm birth.
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USE OF PLECONARIL IN THE TREATMENT OF LIFE
THREATNING NEONATAL ENTEROVIRAL INFECTION
Haider S*1, Tesky L2; 1McMaster University Faculty
of Medicine, Division of Infectious Diseases and
2Dept of Pediatrics
BACKGROUND: Enterovirus family of viruses are re-
sponsible for 10—15 million symptomatic infections
per year in the USA. Most infections are selﬂim-
ited, but severe life threatening infections such
as myocarditis, meningitis, encephalitis, neonatal
sepsis and polio are well recognized. Pleconaril is
antiviral compound with excellent in vitro activity
against enteroviruses. We describe the success-
ful use of Pleconaril in a case of severe neonatal
sepsis and review the literature. Case: A 34 wk
male baby was delivered by C-Section due to fe-
tal tachycardia and transverse lie. One day prior
to delivery his mother was unwell presenting with
fever, headache, cough, and abdominal pain. She
was treated with steroids and parenteral antibi-
otics for chorioamnionitis. At delivery Apgar scores
were 5 and 7 at one and ﬁve minutes. Baby was
treated with Ampicillin and Gentamicin and intu-
bated for mild RDS for 24 hours then extubated.
His septic w/up at the time including blood cul-
tures, WBC, and CSF were all normal. On day 5
of life, he was noted to be febrile and lethargic,
repeat septic w/up: high WBC with left shift, CSF
1889 cells 70% neutrophils, blood and CSF cultures
were negative. He was started on cefotaxime and
acyclovir. He was noted to have abnormal postur-
ing, CT head showed meningeal enhancement, EEG
consistent with hypoxic insult. Chest X-ray showed
bilateral pneumonia. He was subsequently noted
to have acalculous cholecystitis on abdominal ul-
trasound with transaminitis and DIC: AST peak
3750U/L ALT 779U/L, bilirubin 149 umol/l, INR 3.1
and PT greater than 150 sec. Therapy was switched
to Meropenem. On day 10 of life nasopharyngeal
and stool cultures were reported positive for Cox-
sackie B5 virus. He was treated with IVIG 1 g/kg on
day 10 of life for severe enteroviral infection. On
day 12 of life with no improvement, he was put
on Pleconaril at 10mg/kg po t.i.d for 7 days. NP
and stool cultures were negative for coxsackie B5
virus at 72 hrs of pleconaril therapy. Liver enzymes
dramatically improved, with resolution of coagu-
lopathy, pneumonia, and hepatitis. Child was noted
at 5 months of age to have optic atrophy, felt to be
secondary to CNS effects of enteroviral infection.
DISCUSSION: This case illustrates how enteroviral
infection in the neonate, mimicks bacterial sep-
sis. Pleconaril is a novel antiviral agent, which has
been studied in life threatening enteroviral infec-
tions in adults and children. There a limited num-
ber of neonatal cases of severe enteroviral infec-
tion treated with pleconaril with a success rate of
90% (9/10 survived, some with mild sequelae). Most
neonatal enteroviral infections are acquired in the
peripartum period, and therefore maternal viral ill-
ness in the peripartum period should alert clinicians
to screen for enterovirus in a neonate presenting
with sepsis.
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DC-DEVELOPED FROM CD34+ CELLS AS EXPERI-
MENTAL MODEL FOR ANTICANCER IMMUNOTHER-
APY
Lazarova P, Kvalheim G, Nesland J; Clin. Lab, Dis-
trict Hosp. ‘‘St. Anna’’, Varna-Bulgaria, Lab. Stem
Cells, The Norwegian Radium Hospital, Oslo, Nor-
way, Dept. Pathology, The Norwegian Radium Hos-
pital, Oslo, Norway
Dendritic cells (DC) are the most powerful antigen-
presenting cells, specialized to initiate and reg-
ulate the immune response. Their clinical use
as cellular adjuvants in vaccination strategies is
well-known. Enriched CD34+ can be expanded
to become DC-cells ex-vivo and the serum-free
culture procedure provides better conditions for
production of DC-cells.
The present study aims to establish ex-vivo culture
conditions for expansion and preparation of DC for
clinical use and to test the optimal immunologic
properties of these cells: the authors try to opti-
mize serum-free culture conditions for expansion of
CD34+ derived DC and to evaluate phenotypically
by ﬂowcytometry and immunohistochemistry mat-
urated DC.
MATERIALS AND METHODS: (a) cell sources - leuka-
pheresis harvest samples are obtained from cancer
patients undergoing peripheral blood stem cell mo-
bilization. The mean purity of 19 samples was 89%.
(b) media - Dulbecco’s Modiﬁed Eagle Medium sup-
plemented with 10% FCS; alternatively - serum-free
CellGro/SCGM (CellGenix) supplemented with 25%
Albumin. (c) DC cultures - CD34+ enriched cells in
culture bags (CellGenix). (d) Recombinant human
cytokines and growth factors - GM-CSF, TNF-alpha,
IL-4, ﬂt-3, SCF. (e) Monoclonal antibodies - FITC- or
PE-labeled maBs against CD1a, CD14, CD33, CD34,
CD40, CD80, CD83, CD86, HLA-DR.
RESULTS: Our results show that the serum-free
culture conditions with appropriate combination
of cytokines allow generation of large amounts
of CD from CD34+ progenitors. The differentia-
tion of CD34+ cells into mature DC is analyzed
ﬂowcytometrically. The DC phenotyping conﬁrms
a high expression of CD86, CD83, CD40, CD80
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and HLA-DR, whereas CD14 and CD33 are less ac-
tively expressed. The overall evaluation of the
achieved results allow the authors to continue
with the next steps (examination of stimulatory
capacity and immunologic properties of ex-vivo
cultured DC, by T-stimulation, transfection and
ability of cultured DC to induce T-cell proliferation
in MLR), which will give a green light for clinical
application.
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LARGE GRANULAR LYMPHOCYTES AND MYCOBAC-
TERIAL INFECTIONS: IS ANYONE TO BLAME?
Uzel G*, Brown MR, Han-Sarro X, Holland SM;
Children’s Memorial Hospital, Feinberg School of
Medicine, NWU, Chicago, IL and Laboratory of Host
Defenses, NIAID, NIH, Bethesda, MD
Large granular lymphocytes (LGL) may be reac-
tive or part of a lymphoproliferative syndrome.
The spectrum of this condition ranges from poly-
or oligo-clonal expansion, which is usually a mild
asymptomatic lymphocytosis, to an aggressive
T-LGL leukemia. While ﬂow cytometry distinguishes
the more common CD3+/CD8+/CD57+ (T-NK) LGL
effector form from the CD3− variant, documenta-
tion of clonality is essential in evaluation of lym-
phoproliferation. Here we report 23 adult patients
with CD3+ large granular lymphocytosis in the set-
ting of disseminated or pulmonary nontuberculous
mycobacterial (NTM) infection. We have reviewed
their clinical, immunologic, and molecular proﬁles
to explore the relationship between their infection
and clonal expansion of T-NK cells. In patients with
NTM disease, ﬂow cytometric analysis of periph-
eral blood lymphocytes was performed. Patients
with increased (more than 15% of all T cells) T-NKs
(CD3+/CD8+/CD57+) were identiﬁed and T-cell
receptor (TCR) re-arrangements were determined
by PCR. Quantitative immunoglobulin levels were
measured in all patients. Bone marrow biopsies
were performed when indicated. Twenty-three pa-
tients had increased LGL; 19 were female, 6 were
<50 y, 8 were >60 y. Fourteen had pulmonary and
9 disseminated NTM disease: 15 had M. avium com-
plex infection; the remainder were M. abscessus
or M. kansasii. Associated conditions in 1 patient
each were Crohn’s, rheumatoid arthritis and lung
cancer. One male patient had a mutation in the
NFkB Essential Modulator (NEMO). Four patients
with disseminated NTM also had monocytopenia.
CD4 lymphopenia (8 patients) and B cell lymphope-
nia (7 patients) were associated ﬁndings. Only 1
patient had hypogammaglobulinemia. Six patients
had clonal or oligoclonal T cell proliferation. Nei-
ther disseminated disease nor CD4+ and B cell
lymphopenias were a predictor for clonality. Per-
sistent antigenic stimulation may lead to increased
LGLs in this group. Alternatively, they may have
been predisposed to NTM due to the LGL per se.
We can not distinguish these possibilities in this
retrospective cohort. However, it is clear that per-
sistent NTM disease is associated with increased
numbers of LGL, with a high rate of oligoclonal or
clonal proliferation. Further study of whether this
is a cause or a consequence of NTM infection is
ongoing.
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IMMUNOPATHOLOGICAL IMPAIRMENTS AND TORCH
INFECTION IN AUTISTIC CHILDREN: THE BENE-
FIT OF IMMUNOMODULATOR AND ANTIMICROBIAL
AGENTS
Cornain S*; Lab of Immunology, Faculty of Medicine,
University of Indonesia, Salemba 6, Jakarta 10430,
Indonesia
BACKGROUND: Immunological disorders and envi-
ronmental factors, i.e. microbial and toxic agents
might contribute to autism pathogenesis. Such chil-
dren might have immunological defects which are
made worse by speciﬁc infection with noxious char-
acteristic in particular to central nervous system
such as TORCH family (Toxoplasma, Rubella, Cy-
tomegalovirus and Herpes Simplex types I & II, plus
Chlamydia and Mycoplasma for Others). Combined
immunotherapy and antimicrobial agents might be
helpful.
METHODS: Sixty eight autistic children aged less
than 1 to 17 years were tested for TORCH infec-
tion by ELISA. They were also tested for cellular
immunity using ﬂowcytometry (FACSCAN), autoan-
tibodies (anti nuclear antibodies, anti smooth mus-
cles antibodies, anti mitochondrial antibodies),
circulating immune complexes and acute phase
proteins.
RESULTS: The results showed that the proportion
of CD3+ T-cells was low in 49.3% cases (median
= 57, range 7—61), normal in 49.3% cases (median
= 67, range 62—82) and high (89) in one case. The
proportion of B-cells were low in 3% cases (median
= 7.5, range 7—8), normal in 65.2% cases (me-
dian = 14, range 9—20) and high in 31.8% cases
(median = 24, range 21—53). Sixty six percents
showed low level (median = 24, range 10—31) of
helper-T (CD4+) cells while the rest showed nor-
mal level (median = 37, range 32—43). The pro-
portion of suppressor-/cytotoxic-T (CD8+) cells
were low in 3% (median = 5.5, range 5—6), nor-
mal in 78.8% (median = 24.5, range 14—34) and
high in 18.2% (median = 38, range 36—55). Thus,
low Th/Ts ratio was encountered in 58.2% (median
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= 0.82, range 0.24—1.17), normal in 40.3% (median
= 1.59, range 1.28—2.92) and high (4.67) in single
case. Natural Killer cells was low in 15.2% (me-
dian = 6, range 3—7), it was normal in 72.7% (me-
dian = 14, range 8—28) and high in 12.1% (median
= 34, range 29—39). Sixty two percents showed
infections with rubella, 43% with CMV, 0.3% with
chlamydia and 22% with mycoplasma. A proportion
of cases showed elevated -1 antitrypsin, IL-6 and
C3 and/or circulating immune complex, indicating
inﬂammatory process. CNS related autoantibodies
were found in a proportion of cases and not for
the common ones. Intermittent regimen given was
isoprinosine as immunomodulator plus spiramycine
as anti toxoplasma and/or acyclovir/valacyclovir
as antivirus, erythromycine as anti chlamydia/
mycoplasma.
CONCLUSION: Longitudinal follow up revealed sig-
niﬁcant degrees of recovery of the immune sta-
tus, control of opportunistic infections and autistic
spectrum disorders.
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IN VITRO COMPLEMENTATION OF IL12Rb1 DEFI-
CIENCY AND ANALYSIS OF IL12RB1 VARIANTS US-
ING EXPRESSION CONSTRUCTS
van de Vosse E*, de Paus RA, Hoeve MA, van Dis-
sel JT, Ottenhoff THM; Dept. of Infectious Diseases
& Dept. of Immunohematology and Bloodtransfu-
sion, Leiden University Medical Center, Leiden, The
Netherlands
Cell-mediated immunity (CMI) plays an essen-
tial role in human host defense against intra-
cellular bacteria. Type-1 cytokines, particularly
Interferon-g (IFN-g), Interleukin-12 (IL-12) and
Interleukin-23 (IL-23) are essential in CMI. This is
illustrated by patients with unusual severe infec-
tions caused by poorly pathogenic mycobacteria
and Salmonella species, in whom genetic deﬁcien-
cies have been identiﬁed in several key genes in
the type-1 cytokine pathway, including IL12RB1,
the gene encoding the b1 chain of the IL-12 and
IL-23 receptors. Several mutations in IL12RB1 with
deleterious effects on human IL-12R function have
been identiﬁed, including nonsense and missense
mutations. In addition, a number of coding IL12RB1
polymorphisms have been reported. In order to
gain more insight into the effect that IL12RB1 mu-
tations and genetic variations can have on IL-12Rb1
function we have proposed an integrated model
of IL-12Rb1 structure and function (van de Vosse
et al., Immunogenetics, 54:817—829, 2003). To
test the accuracy of our model and to determine
whether certain IL12RB1 variants we have found
in our patients or in the literature are deleteri-
ous we set out to clone and analyse the variants.
Wild-type IL12RB1 (the two common haplotypes:
Q214-M365-G378 and R214-T365-R378) and all
known IL12RB1 variants that cause single aminoacid
substitutions (R173P, C198R, R213W, S74R, R156H,
H438Y, A525T, G594E) were cloned into a retrovi-
ral expression vector (pLZRS). The constructs were
transfected into phoenix packaging cells and viral
supernatant was harvested. Normal Jurkat cells
(cells not expressing IL12RB1) as well as PHA blasts
of a patient completely lacking IL-12Rb1 (due to a
premature stop at amino acid 32) were transduced
with the viral supernatant. We have determined
extracellular and intracellular expression of these
IL-12Rb1 proteins in the transduced cells and mea-
sured the response to IL-12 stimulation on IFN-g
production and cell proliferation. Preliminary re-
sults show a near complete restoration of IL-12R
function when transducing wild-type IL12RB1 in
the patients’ cells. All IL12RB1 variants are cur-
rently tested. We will present the results of the
experiments at the meeting.
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TRANSCRIPTIONAL RESPONSE OF HUMAN MI-
CROGLIAL CELLS TO INTERFERON- GAMMA
Rock RB, Hu S, Deshpande A, Munir S, Peterson PK,
Kapur V; University of Minnesota Medical School,
Minneapolis, MN, USA
Microglial cells are resident macrophages in the
brain and play a pivotal role in the innate and
adaptive immune responses against microbial in-
fections. Interferon (IFN)-gamma is one of the most
important cytokines secreted by T-lymphocytes
that inﬂuence microglial activation. However, the
changes in overall gene expression of human mi-
croglial cells in response to IFN-gamma are not
well understood. Human fetal microglial cells were
stimulated with IFN-gamma and the transcriptional
proﬁle of microglial genes was determined with
human microarray chips. The expression pattern
of a selected group of genes was further vali-
dated with semi-quantitative RT-PCR and ELISA.
IFN-gamma treatment of microglial cells resulted in
up-regulation of 329 genes and down-regulation of
76 genes. Major groups of genes that were induced
include chemokine, IFN-gamma signaling factor and
major histocompatibility complex I and II genes,
but not inducible nitric oxide synthase. Overall,
stimulation of human microglia with IFN-gamma
results in the induction of T-lymphocyte-related
chemokine genes as well as antigen presentation
genes. Future studies will explore the inﬂuence that
IFN-gamma and nutritional elements have on mi-
croglia infected with Mycobacterium tuberculosis.
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DISSEMINATED BCG INFECTION FOLLOWING VAC-
CINATION AGAINST TUBERCULOSIS IN CHILDREN
WITH PRIMARY IMMUNODEFICIENCIES REGISTERED
IN CHILDREN’S MEMORIAL HEALTH INSITUTE,
WARSAW IN PERIOD 1980—2003
Bernatowska E1*, Wolska Kunierz B1*, Pac M1,
Pietrucha B1, Kurenko M, Deptuch1, Zwolska Z2,
Mikou B, Jastrzbska Piotrowska J3; 1Department of
Immunology, Children’s Memorial Health Institute,
Warsaw, Poland; 2Department of Microbiology, In-
stitute of Tuberculosis and Lung Diseases, Warsaw,
Poland; 3Department of Propedeutics of Pediatrics,
The Medical University, Biaystok, Poland
BACKGROUND: Severe adverse events following BCG
vaccination are very rare, but cases of disseminated
disease are noted in patients with congenital or ac-
quired immunodeﬁciencies.
METHOD: Frequency of severe adverse events after
BCG vaccination in children with primary immun-
odeﬁciencies was estimated. Seven hundred four
cases of primary immunodeﬁciencies were diag-
nosed in Department of Immunology, Children’s
Memorial Health Institute in Warsaw between
1980—2003. In 399 cases antibody deﬁciencies were
recognized. Among 187 patients with T-cell or com-
bined immunodeﬁciencies 19 children with SCID,
3 Omen’s syndrome cases and 10 children with Di
Georgea anomaly were registered. The group of
phagocytic disorders consisted of 77 patients. De-
ﬁciencies of IFN gamma receptor was recognized
in 4 children, we noticed one case of IL-12 recep-
tor deﬁciency. In the group of 33 patients with
other deﬁciencies hyper IgE syndrome was the most
frequent.
RESULTS: Severe adverse events following BCG
vaccination was recognized in 9 children. Three
children with severe combined immunodeﬁciency
died cause of disseminated BCG infection with
multi-organ involvement. In one boy with X-linked
SCID we observed disseminated BCG infection after
BMT procedure with skin, liver and bones involve-
ment. After 15 month of antituberculous treatment
he made a full recovery with full immunological
reconstitution after transplantation. Another boy
with SCID due to RAG 2 deﬁciency developed se-
vere local inﬂammation at the site of BCG injection
3 months after BMT, and also had a good response
on treatment.
In group of 4 children with IFN-gamma receptor de-
ﬁciency: one girl died cause of disseminated BCG
infection, 2 patients with disseminated infection
recovered on antituberculous treatment. In a girl
with severe local reaction at site of BCG injection
with purulent adenitis a deﬁciency of IL-12 recep-
tor was recognized.
CONCLUSION: Severe adverse events following BCG
vaccination were observed in 23.8% of patients
with severe combined immunodeﬁciencies with
high mortality rate; 60%. Immunological reconsti-
tution following BMT probably was associated with
full recovery on antituberculous treatment in two
patients. The course of BCG infection in group of
patients with IFN- gamma pathway deﬁciencies
were milder with mortality rate 25% and full recov-
ery in 75% of cases.
